GOVX: Phase 2A. Human AIDS vax injection program begins?
The update a few months back targeted January, 2017 as the start date for injecting HUMANS with the vaccine. This is a second round of injections with boosters from the highly successful 1st round.
Yesterday, GOVX noted:
"GeoVax is committed to an AIDS-free generation through vaccine development. Our HIV vaccine candidate is currently progressing through human clinical trials conducted by the HIV Vaccine Trials Network (HVTN) with support from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). To learn more about our work to fight HIV, visit:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.